Format

Send to

Choose Destination
Heart Rhythm. 2013 Dec;10(12):1919-26. doi: 10.1016/j.hrthm.2013.10.019. Epub 2013 Oct 9.

Current treatment of ventricular arrhythmias: state of the art.

Author information

1
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: wstevenson@partners.org.

Abstract

Ventricular arrhythmias may be benign, requiring only evaluation for associated risks and then reassurance, or associated with a risk of sudden death or significant morbidity. Therapies for these arrhythmias have evolved considerably over the past 20 years. For some, a definitive, curative therapy is available in the form of catheter ablation. Others are best managed with an implantable cardioverter-defibrillator that provides effective arrhythmia termination and protection from sudden death, with antiarrhythmic drugs or ablation to control recurrent arrhythmias. Although progress has been substantial, many challenges remain.

KEYWORDS:

Ablation; Antiarrhythmic drug; Implantable cardioverter-defibrillator; Ventricular tachycardia

PMID:
24120875
DOI:
10.1016/j.hrthm.2013.10.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center